|
|
|
Volumn 28, Issue 5, 1996, Pages 2491-2493
|
|
Antirejection strategy in small bowel transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
15 DEOXYSPERGUALIN;
ANTIBODY CONJUGATE;
AZATHIOPRINE;
BREQUINAR;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
LEFLUNOMIDE;
LYMPHOCYTE ANTIBODY;
METHYLPREDNISOLONE;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISOLONE;
PROSTAGLANDIN E1;
RAPAMYCIN;
STEROID;
TACROLIMUS;
CLINICAL TRIAL;
CONFERENCE PAPER;
DONOR;
DRUG BLOOD LEVEL;
GRAFT REJECTION;
GRAFT SURVIVAL;
GRAFT VERSUS HOST REACTION;
HLA MATCHING;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE TRANSPLANTATION;
INTRAVENOUS DRUG ADMINISTRATION;
IRRADIATION;
LYMPH NODE IRRADIATION;
MULTICENTER STUDY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REPERFUSION INJURY;
ANIMALS;
GRAFT REJECTION;
GRAFT VS HOST DISEASE;
HISTOCOMPATIBILITY TESTING;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINE, SMALL;
KIDNEY TRANSPLANTATION;
REPERFUSION INJURY;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0029838688
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (0)
|
